1. Home
  2. IGC vs MXC Comparison

IGC vs MXC Comparison

Compare IGC & MXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGC
  • MXC
  • Stock Information
  • Founded
  • IGC 2005
  • MXC 1972
  • Country
  • IGC United States
  • MXC United States
  • Employees
  • IGC N/A
  • MXC N/A
  • Industry
  • IGC Biotechnology: Pharmaceutical Preparations
  • MXC Oil & Gas Production
  • Sector
  • IGC Health Care
  • MXC Energy
  • Exchange
  • IGC Nasdaq
  • MXC Nasdaq
  • Market Cap
  • IGC 26.9M
  • MXC 24.0M
  • IPO Year
  • IGC N/A
  • MXC N/A
  • Fundamental
  • Price
  • IGC $0.35
  • MXC $12.10
  • Analyst Decision
  • IGC Strong Buy
  • MXC
  • Analyst Count
  • IGC 2
  • MXC 0
  • Target Price
  • IGC $3.63
  • MXC N/A
  • AVG Volume (30 Days)
  • IGC 222.5K
  • MXC 9.3K
  • Earning Date
  • IGC 11-12-2024
  • MXC 11-07-2024
  • Dividend Yield
  • IGC N/A
  • MXC 0.82%
  • EPS Growth
  • IGC N/A
  • MXC N/A
  • EPS
  • IGC N/A
  • MXC 0.57
  • Revenue
  • IGC $1,183,000.00
  • MXC $6,926,917.00
  • Revenue This Year
  • IGC N/A
  • MXC N/A
  • Revenue Next Year
  • IGC $13.57
  • MXC N/A
  • P/E Ratio
  • IGC N/A
  • MXC $21.44
  • Revenue Growth
  • IGC N/A
  • MXC N/A
  • 52 Week Low
  • IGC $0.25
  • MXC $9.02
  • 52 Week High
  • IGC $0.91
  • MXC $16.52
  • Technical
  • Relative Strength Index (RSI)
  • IGC 42.76
  • MXC 48.96
  • Support Level
  • IGC $0.33
  • MXC $11.75
  • Resistance Level
  • IGC $0.42
  • MXC $13.36
  • Average True Range (ATR)
  • IGC 0.02
  • MXC 0.55
  • MACD
  • IGC -0.00
  • MXC 0.02
  • Stochastic Oscillator
  • IGC 32.14
  • MXC 31.89

About IGC IGC Pharma Inc.

IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

About MXC Mexco Energy Corporation

Mexco Energy Corporation is an independent oil and gas company. It is engaged in the exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.

Share on Social Networks: